Get a free quote now.
Taking model-informed precision dosing one step farther
We’re proud to announce our latest feature, DoseAssist! DoseAssist is designed to improve clinician efficiency by displaying dosing regimens most likely to get patients to PK/PD targets quickly.
Model-informed precision dosing (MIPD) greatly simplifies the process of accurately estimating PK/PD targets. But we found that our users spend a lot of time repetitively entering different regimens to see which ones get patients to the right target. To eliminate this inefficient trial-and-error process, we developed DoseAssist.
Available exclusively in InsightRX Nova, DoseAssist automatically simulates and displays regimens predicted to be most likely to achieve desired PK/PD targets.
The first and only precision dosing system to suggest regimens predicted to meet pharmacokinetic targets
Starting with InsightRX Nova v1.23, DoseAssist is available for vancomycin and busulfan drug modules. DoseAssist will be made available for additional drug modules in future releases.
In the InsightRX vancomycin (adult) drug module, DoseAssist shows:
In vancomycin (pediatric and neonate) and busulfan drug modules, DoseAssist shows:
InsightRX assigns a Clinician Preference Score to all dosing regimens composed of the most commonly used doses and dosing intervals for a given drug. The Clinician Preference Score was developed by clinical pharmacists and accounts for ease of compounding, logistical convenience, and conventional practice for a given drug.
Don’t settle for a simple dosing calculator
We’re committed to integrating MIPD as seamlessly as possible in the clinical workflow, and that means improving InsightRX Nova beyond a dosing calculator into a clinical decision support system that helps you spend your valuable time and expertise where they’re most needed.
To see DoseAssist in action, click the Request Trial button or email firstname.lastname@example.org.